Home LiteratureArticle Details
PMID: 1510447 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.

Antimicrobial agents and chemotherapy ·Vol. 36 ·No. 7 ·1992-07-00 ·Pages 1504-13

Clairoux N, Picard M, Brochu A, Rousseau N, Gourde P, Beauchamp D, Parr TR, Bergeron MG, Malouin F

Abstract

A study recently conducted across Canada showed that 64 of 2,503 clinical isolates of Haemophilus influenzae were resistant to beta-lactams without production of a beta-lactamase (L. D. Tremblay, J. L'Ecuyer, P. Provencher, M. G. Bergeron, and Canadian Study Group, Can. Med. Assoc. J. 143:895-900, 1990). The beta-lactamase-negative strains formed three distinct groups, with ampicillin MICs of 0.5 to 1, 2 to 4, and greater than or equal to 8 micrograms/ml for groups I, II, and III, respectively. We have investigated the mechanisms of resistance for eight strains originating from different infections and geographic areas. These strains were representative of groups I to III. Five strains were nontypeable, two were type B, and one was non-B. Chromosomal DNA extracted from each strain was used to transform the laboratory strain Rd. Transformants were selected on beta-lactam-containing plates and showed the same level of resistance to ampicillin as the donor strains. Differences in outer membrane proteins, porins, and lipopolysaccharide profiles on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) did not change with resistance. Functional analyses of purified porins in artificial lipid bilayer experiments did not explain resistance. Peptidoglycan synthesis was measured by incorporation of [14C]alanine into trichloroacetic acid-insoluble cell wall material in the presence of chloramphenicol. The growth rate and the rate of peptidoglycan synthesis observed for the transformants of the isogenic set did not correlate with resistance. Whole-cell labeling with 125I-penicillin revealed modifications in penicillin-binding proteins (PBPs) among the transformants. In particular, PBPs 3A and 3B (65 and 63 kDa, respectively) showed a decrease in affinity for beta-lactams in all transformants (groups I, II, and III) and correlated with an increased MIC except in the transformant of group III, which showed higher levels of resistance. Partial purification and proteolytic digestion of 125I-penicillin-labeled PBP 3B led to two types of CnBr peptide profiles on SDS-PAGE, the profiles of the transformed strains from groups I and II being different from those of the control group and group III. Finally, electron microscopy revealed a distinct cell filamentation for the group III transformants. These data clearly indicate that changes in PBPs are a common mechanism that results in a significant level of non-beta-lactamase-mediated beta-lactam resistance in H. influenzae despite serotype, origin of isolation, or geographic distribution.

MeSH Terms
Adolescent Adult Aged Anti-Bacterial Agents/pharmacology Autoradiography Bacterial Outer Membrane Proteins/isolation & purification Bacterial Proteins Canada Carrier Proteins/metabolism Cells, Cultured Child, Preschool Electrophoresis, Polyacrylamide Gel Haemophilus influenzae/drug effects,isolation & purification,metabolism Hexosyltransferases Humans Microbial Sensitivity Tests Middle Aged Muramoylpentapeptide Carboxypeptidase/metabolism Penicillin-Binding Proteins Peptidoglycan/biosynthesis Peptidyl Transferases beta-Lactamases/metabolism beta-Lactams
Chemicals
Anti-Bacterial Agents Bacterial Outer Membrane Proteins Bacterial Proteins Carrier Proteins Penicillin-Binding Proteins Peptidoglycan beta-Lactams Peptidyl Transferases Hexosyltransferases Muramoylpentapeptide Carboxypeptidase beta-Lactamases
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Clairoux N
Département de Microbiologie, Hospitalier de l'Université Laval, Sainte-Foy, Québec, Canada.
Picard M
Brochu A
Rousseau N
Gourde P
Beauchamp D
Parr T R
Bergeron M G
Malouin F
References (34)
34 references, click to expand
  1. Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species.
    J Clin Microbiol. 1986 Sep;24(3):330-2 PMID: 3489731
  2. Properties of the penicillin-binding proteins of Escherichia coli K12,.
    Eur J Biochem. 1977 Jan;72(2):341-52 PMID: 319999
  3. The biology of natural transformation.
    Annu Rev Microbiol. 1986;40:211-35 PMID: 3535646
  4. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.
    Rev Infect Dis. 1987 Jan-Feb;9(1):1-15 PMID: 3547567
  5. Cloning and expression of genes responsible for altered penicillin-binding proteins 3a and 3b in Haemophilus influenzae.
    Antimicrob Agents Chemother. 1987 Feb;31(2):286-91 PMID: 3551833
  6. Maturation of the head of bacteriophage T4. I. DNA packaging events.
    J Mol Biol. 1973 Nov 15;80(4):575-99 PMID: 4204102
  7. Defined nongrowth media for stage II development of competence in Haemophilus influenzae.
    J Bacteriol. 1970 Feb;101(2):517-24 PMID: 5308771
  8. Influence of growth media on Escherichia coli cell composition and ceftazidime susceptibility.
    Antimicrob Agents Chemother. 1991 Mar;35(3):477-83 PMID: 1674848
  9. Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins.
    Antimicrob Agents Chemother. 1990 May;34(5):718-21 PMID: 2113792
  10. Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency.
    J Antimicrob Chemother. 1990 Jun;25(6):995-1010 PMID: 2115039
  11. Outer membrane and porin characteristics of Serratia marcescens grown in vitro and in rat intraperitoneal diffusion chambers.
    Infect Immun. 1990 May;58(5):1247-53 PMID: 2157667
  12. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.
    Antimicrob Agents Chemother. 1990 Jan;34(1):139-47 PMID: 2158272
  13. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    CMAJ. 1990 Nov 1;143(9):895-901 PMID: 2224717
  14. Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles.
    Antimicrob Agents Chemother. 1990 Feb;34(2):363-5 PMID: 2327782
  15. Outer membrane porin protein of Haemophilus influenzae type b: pore size and subunit structure.
    Can J Microbiol. 1988 Feb;34(2):134-40 PMID: 2456850
  16. Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b.
    J Bacteriol. 1985 Jun;162(3):918-24 PMID: 2987194
  17. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae.
    Nature. 1988 Mar 10;332(6160):173-6 PMID: 3126399
  18. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
    J Bacteriol. 1983 Apr;154(1):269-77 PMID: 6187729
  19. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae.
    Antimicrob Agents Chemother. 1984 Aug;26(2):235-44 PMID: 6333208
  20. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.
    Antimicrob Agents Chemother. 1984 Jun;25(6):747-53 PMID: 6611136
  21. Penicillin is an active-site inhibitor for four genera of bacteria.
    J Bacteriol. 1982 Mar;149(3):1150-3 PMID: 7061385
  22. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  23. Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins.
    J Infect Dis. 1990 Nov;162(5):1118-23 PMID: 2230238
  24. Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.
    Antimicrob Agents Chemother. 1987 Jul;31(7):1093-9 PMID: 2821889
  25. Properties of the porin of Haemophilus influenzae type b in planar lipid bilayer membranes.
    Biochim Biophys Acta. 1986 Sep 25;861(1):74-82 PMID: 3019399
  26. DNA probe technology for rapid detection of Haemophilus influenzae in clinical specimens.
    J Clin Microbiol. 1988 Oct;26(10):2132-8 PMID: 3263384
  27. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance.
    Antimicrob Agents Chemother. 1986 Jul;30(1):1-5 PMID: 3530121
  28. Antibiotic tolerance among clinical isolates of bacteria.
    Antimicrob Agents Chemother. 1986 Oct;30(4):521-7 PMID: 3539006
  29. Antibiotic tolerance among clinical isolates of bacteria.
    Rev Infect Dis. 1985 May-Jun;7(3):368-86 PMID: 3895353
  30. A simple method for following the fate of alanine-containing components in murein synthesis in Escherichia coli.
    Antonie Van Leeuwenhoek. 1971;37(4):537-52 PMID: 4945310
  31. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
  32. The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.
    J Antimicrob Chemother. 1983 Nov;12(5):435-49 PMID: 6608514
  33. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 1980 Mar;17(3):434-42 PMID: 6903436
  34. Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae.
    J Gen Microbiol. 1986 Oct;132(10):2855-61 PMID: 3498005
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1992-07-00
Pages
1504-13
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC191612
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]